Showing results (541-550 of 760) with videos related to

Sort By:
Pageof 76
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2003
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosisGyanu Lamichhane, Matteo Zignol, Natalie J Blades, et al.
The American Journal of Pathology|April 13, 2010
Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cellsMélanie Demers, April A N Rose, Andrée-Anne Grosset, et al.
Nucleic Acids Research|October 20, 2011
Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a modelSandra Jalvy-Delvaille, Marion Maurel, Vanessa Majo, et al.
Journal of Parkinson'S Disease|January 13, 2024
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert PanelCamille Carroll, Carl E Clarke, Donald Grosset, et al.
Acta Leprologica|October 1, 1986
[Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences]J Millan, G Roux, S Loko, et al.
BMC Geriatrics|January 14, 2021
Muscles adaptation to aging and training: architectural changes - a randomised trialAdrien J Létocart, Franck Mabesoone, Fabrice Charleux, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2010
PA-824 exhibits time-dependent activity in a murine model of tuberculosisZahoor Ahmad, Charles A Peloquin, Rajendra P Singh, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profileD Caille, O E Bergis, C Fankhauser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le SidaT May, F Brel, C Beuscart, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisEric Nuermberger, Ian Rosenthal, Sandeep Tyagi, et al.
Pageof 76